Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors
Yongfu Liu(Guangzhou University), Xuefei Tan(Roche (China)), Stephan Kirchner(Roche (Switzerland)), Hans-Peter Märki(Roche (Switzerland)), A. Mayweg(Roche (Switzerland)), Philippe Verry(Roche (Switzerland)), William Riboulet(Roche (Switzerland)), Giorgio Ottaviani(Roche (China)), Bernd Kuhn(Roche (Switzerland)), Hong C. Shen(Southern Medical University), Mingwei Zhou(Roche (China)), A. Kuglstatter(Roche (Switzerland)), Jun Wu(Nova Southeastern University), Wenming Chen(Roche (China)), Lisha Wang(Hainan Medical University), Dongbo Li(Roche (China)), Susanne Mohr(Roche (Switzerland)), Stephan Müller(Roche (Switzerland)), Zhanguo Wang(Roche (China)), Remo Hochstrasser(Roche (Switzerland)), Jörg Benz(Roche (Switzerland)), Johannes D. Aebi(Roche (Switzerland)), Kurt E. Amrein(Roche (Switzerland)), Jian Xin(Roche (China)), Benoit Hornsperger(Roche (Switzerland))
Cited by 20
Related Papers
A Medicinal Chemist’s Guide to Molecular Interactions
|Journal of Medicinal Chemistry|2010|1.7k
Fluorine in Medicinal Chemistry
|ChemBioChem|2004|1.5k
Report from the in vitro micronucleus assay working group
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2003|625
Intramolecular Hydrogen Bonding in Medicinal Chemistry
|Journal of Medicinal Chemistry|2010|566